• Publications
  • Influence

Claim Your Author Page
Ensure your research is discoverable on Semantic Scholar. Claiming your author page allows you to personalize the information displayed and manage publications (all current information on this profile has been aggregated automatically from publisher and metadata sources).
  • A P Magiorakos, Adithya Srinivasan, +14 authors Dominique L. Monnet
  • Medicine
  • Clinical microbiology and infection : the…
  • 2012 (First Publication: 1 March 2012)
  • Many different definitions for multidrug-resistant (MDR), extensively drug-resistant (XDR) and pandrug-resistant (PDR) bacteria are being used in the medical literature to characterize the differentContinue Reading
  • S. E. Cosgrove, George Sakoulas, Eli N. Perencevich, Mitchell J. Schwaber, Adolf W. Karchmer, Yehuda Carmeli
  • Medicine
  • Clinical infectious diseases : an official…
  • 2003
  • A meta-analysis was performed to summarize the impact of methicillin-resistance on mortality in Staphylococcus aureus bacteremia. A search of the MEDLINE database for studies published during theContinue Reading
  • Brandon Kitchel, J. Kamile Rasheed, +5 authors Christian G. Giske
  • Biology, Medicine
  • Antimicrobial agents and chemotherapy
  • 2009 (First Publication: 1 August 2009)
  • Klebsiella pneumoniae carbapenemase (KPC)-producing Enterobacteriaceae have become more common in the United States and throughout the world. We used pulsed-field gel electrophoresis (PFGE) andContinue Reading
  • John J. Engemann, Yehuda Carmeli, +6 authors Keith S Kaye
  • Medicine
  • Clinical infectious diseases : an official…
  • 2003 (First Publication: 1 March 2003)
  • Data for 479 patients were analyzed to assess the impact of methicillin resistance on the outcomes of patients with Staphylococcus aureus surgical site infections (SSIs). Patients infected withContinue Reading
  • Mitchell J. Schwaber, Shiri Klarfeld-Lidji, Shiri Navon-Venezia, David F. Schwartz, Azita Leavitt, Yehuda Carmeli
  • Medicine
  • Antimicrobial agents and chemotherapy
  • 2008 (First Publication: 1 March 2008)
  • Carbapenem-resistant Klebsiella pneumoniae (CRKP) is an emerging nosocomial pathogen. Little is known about its risk factors or mortality. We performed a case-case-control study to assess the risksContinue Reading
  • Ronen Ben-Ami, Jesús Rodríguez-Baño, +9 authors Yehuda Carmeli
  • Medicine
  • Clinical infectious diseases : an official…
  • 2009 (First Publication: 1 September 2009)
  • BACKGROUND Infections caused by extended-spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae are increasing in frequency and are associated with high mortality rates. Circulation ofContinue Reading
  • S. E. Cosgrove, Youlin Qi, Keith S Kaye, Stephan Harbarth, Adolf W. Karchmer, Yehuda Carmeli
  • Medicine
  • Infection control and hospital epidemiology
  • 2005 (First Publication: 1 February 2005)
  • OBJECTIVE To evaluate the impact of methicillin resistance in Staphylococcus aureus on mortality, length of hospitalization, and hospital charges. DESIGN A cohort study of patients admitted to theContinue Reading
  • Azita Leavitt, Shiri Navon-Venezia, Inna Chmelnitsky, Mitchell J. Schwaber, Yehuda Carmeli
  • Biology, Medicine
  • Antimicrobial agents and chemotherapy
  • 2007 (First Publication: 1 August 2007)
  • Carbapenem resistance due to KPC has rarely been observed outside the United States. We noticed a sharp increase in carbapenem-resistant Klebsiella pneumoniae strains possessing KPC in Tel AvivContinue Reading